Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESS Newswire / February 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
News Medical15h
No extra benefit from mechanical clot removal over medications in some strokes
Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical ...
Clot-buster meds and mechanical retrieval found to equally reduce disability from some strokes
Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of ...
Hosted on MSN21h
Akura enrols first subject in pulmonary embolism trial of thrombectomy system
Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana ...
American Association of Individual Investors1d
Which Is a Better Investment, Glaukos Corporation or Inari Medical, Inc. Stock?
Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...
Zacks.com on MSN1d
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...